Launching symposium on Glufast held

A symposium to mark the launch of Glufast tablets (mitiglinide), a drug for the treatment of type 2 diabetes, was held at the Marriott Hotel in downtown Seoul recently, according to Choong-wae Pharm.

Glufast, an insulin secretagogue with a rapid onset and short duration of action, lowers post-meal glucose levels by improving the body's own ability to produce insulin.

The company said abou...